---
created: 2025-04-13
updated: 2025-04-13T10:51
id: e%&)5h!Q*P
specialty: cardio
specialty_id: 200
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - source/ak-step1-v11::
  - theme/b&b::03-biochem::05-lipids::03-lipid-drugs
  - source/ak-step1-v11::
  - theme/firstaid::07-cardiovascular::05-pharm::10-lipid-lowering-agents::fibrates
  - source/ak-step1-v11::
  - theme/nbme::18
  - source/ak-step1-v11::
  - source/ome-banner::basic-science::09-cardiac
  - source/ak-step1-v11::
  - theme/physeo::09-pharm::10-cardiac::12-fibrates
  - source/ak-step1-v11::
  - theme/pixorize::03-pharm::06-cardio::fibrates
  - source/ak-step1-v11::
  - theme/sketchypharm::03-blood-&-inflammation::02-dyslipidemia-drugs::03-fibrates,-niacin
  - source/ak-step1-v11::
  - theme/uworld::10000-99999::11000-11999::11844
  - source/ak-step1-v11::^other::^highyield::1-highyield
  - source/ak-step1-v11::^systems::cardio::pharmacology"
type: flashcard
---

# Question
Fibrates significantly decrease serum **triglycerides** by increasing **hydrolysis** of VLDLs and chylomicrons

---

# Answer
increased LPL activity via PPAR-a stimulation leads to increase triglyceride clearance